Financials Sinocare Inc.

Equities

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 16/07/2024 am IST			5-day change	1st Jan Change
22.9 ^CNY	-1.59%		+2.19%	-24.67%

03/07	Tranche Update on Sinocare Inc.'s Equity Buyback Plan announced on August 7, 2023.	CI
07/06	Sinocare Inc. Announces Dividend Implementation for 2023, Payable on 17 June 2024	CI

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	8,425	20,027	16,800	18,795	16,906	12,683	-	-
Enterprise Value (EV) ¹	8,425	20,027	16,800	18,795	16,906	12,683	12,683	12,683
P/E ratio	33.7 x	107 x	156 x	43.7 x	59.5 x	29.8 x	23.2 x	20 x
Yield	2%	-	-	0.59%	0.66%	1.19%	1.38%	2.27%
Capitalization / Revenue	4.74 x	9.94 x	7.11 x	6.68 x	4.17 x	2.74 x	2.37 x	2.13 x
EV / Revenue	4.74 x	9.94 x	7.11 x	6.68 x	4.17 x	2.74 x	2.37 x	2.13 x
EV / EBITDA	24.5 x	62.3 x	41.8 x	32.4 x	35.9 x	17 x	14.3 x	12.2 x
EV / FCF	-	-	-	115 x	43.2 x	40.5 x	23.1 x	20.4 x
FCF Yield	-	-	-	0.87%	2.32%	2.47%	4.32%	4.9%
Price to Book	3.2 x	7.76 x	6.35 x	6.35 x	5.81 x	3.76 x	3.26 x	2.91 x
Nbr of stocks (in thousands)	5,62,014	5,59,413	5,61,673	5,57,223	5,56,128	5,53,845	-	-
Reference price ²	14.99	35.80	29.91	33.73	30.40	22.90	22.90	22.90
Announcement Date	14/02/20	16/04/21	21/04/22	06/04/23	25/04/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	1,778	2,015	2,361	2,814	4,059	4,624	5,357	5,968
EBITDA ¹	343.3	321.4	402.1	580.5	471.5	747.3	886.7	1,043
EBIT ¹	274.2	236.2	139.3	470.2	275	469.1	629.9	740.1
Operating Margin	15.42%	11.72%	5.9%	16.71%	6.78%	10.14%	11.76%	12.4%
Earnings before Tax (EBT) ¹	301.5	247.8	138.2	470	248.6	463.2	626.6	736.3
Net income ¹	250.7	186.9	107.6	430.9	284.4	431.6	556	646.4
Net margin	14.1%	9.27%	4.56%	15.31%	7.01%	9.33%	10.38%	10.83%
EPS ²	0.4445	0.3341	0.1916	0.7719	0.5107	0.7680	0.9850	1.145
Free Cash Flow ¹	-	-	-	163.5	391.6	313.1	548.1	621.2
FCF margin	-	-	-	5.81%	9.65%	6.77%	10.23%	10.41%
FCF Conversion (EBITDA)	-	-	-	28.17%	83.05%	41.9%	61.81%	59.56%
FCF Conversion (Net income)	-	-	-	37.96%	137.7%	72.56%	98.58%	96.09%
Dividend per Share ²	0.3000	-	-	0.2000	0.2000	0.2733	0.3167	0.5200
Announcement Date	14/02/20	16/04/21	21/04/22	06/04/23	25/04/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-	-	-
Net Cash position	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Free Cash Flow ¹	-	-	-	164	392	313	548	621
ROE (net income / shareholders' equity)	9.5%	7.12%	3.87%	14.7%	9.24%	12.8%	14.3%	14.8%
ROA (Net income/ Total Assets)	-	-	-	9.83%	4.69%	6%	7.6%	6.7%
Assets ¹	-	-	-	4,385	6,061	7,193	7,315	9,648
Book Value Per Share ²	4.690	4.620	4.710	5.310	5.240	6.090	7.020	7.880
Cash Flow per Share ²	0.9200	0.8900	0.8500	0.8400	1.300	1.030	1.140	1.330
Capex ¹	422	276	404	311	344	327	319	307
Capex / Sales	23.73%	13.67%	17.1%	11.05%	8.46%	7.08%	5.95%	5.15%
Announcement Date	14/02/20	16/04/21	21/04/22	06/04/23	25/04/24	-	-	-

¹CNY in Million²CNY

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

22.9 CNY

Average target price

29.68 CNY

Spread / Average Target

+29.61%

	1st Jan change	Capi.
SINOCARE INC.	-24.67%	1.78B
ABBOTT LABORATORIES	-6.76%	179B
MEDTRONIC PLC	-5.71%	98.84B
BECTON, DICKINSON AND COMPANY	-5.41%	65.34B
HOYA CORPORATION	+15.46%	45.41B
DEXCOM, INC.	-6.91%	44.94B
CENCORA, INC.	+9.70%	43.76B
METTLER-TOLEDO INTERNATIONAL, INC.	+13.43%	29.01B
TERUMO CORPORATION	+19.39%	25.65B
WEST PHARMACEUTICAL SERVICES, INC.	-6.66%	23.32B